Contribution of hepatic adenosine A1 receptors to renal dysfunction associated with acute liver injury in rats

Hepatology

Volumn 44, Issue 4, 2006, Pages 813-822

  Ming, Zhi ^a   Fan, Yi Jun ^a   Yang, Xi ^a   Lautt, W Wayne ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3,7 DIMETHYL 1 PROPARGYLXANTHINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 8 PHENYLTHEOPHYLLINE; ADENOSINE A1 RECEPTOR; THIOACETAMIDE; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; 3,7-DIMETHYL-1-PROPARGYLXANTHINE; 8-PHENYLTHEOPHYLLINE; ADENOSINE A2 RECEPTOR; DRUG DERIVATIVE; SODIUM; THEOBROMINE; THEOPHYLLINE; XANTHINE DERIVATIVE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GLOMERULUS FILTRATION RATE; KIDNEY FAILURE; LIVER INJURY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DENERVATION; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; INNERVATION; LIVER; LIVER DISEASE; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; URINE;

ANIMALS; DENERVATION; DISEASE MODELS, ANIMAL; LIVER; LIVER DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; RECEPTORS, ADENOSINE A2; RENAL INSUFFICIENCY; SODIUM; THEOBROMINE; THEOPHYLLINE; THIOACETAMIDE; URINE; XANTHINES;

EID: 33750623708     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21336     Document Type: Article

References (44)

1. Wilkinson SP, Arroyo VA, Moodie H, Blendis LM, Williams R. Abnormalities of sodium excretion and other disorders of renal function in fulminant hepatic failure. Gut 1976;17:501-505.
2. Wilkinson SP, Blendis LM, Williams R. Frequency and type of renal and electrolyte disorders in fulminant hepatic failure. Br Med J 1974;1:186-189.
3. Ellis AJ, O'Grady JG. Clinical disorders of renal function in acute liver failure. In: Arroyo V, Ginès P, Rodés J, Schrier RW, eds. Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment. Maiden, MA: Blackwell Science, 1999:36-62.
4. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119:1637-1648.
5. Gines P, Guevara M, Arroyo V, Rodes J. Hepatorenal syndrome. Lancet 2003;362:1819-1827.
6. Gines P, Arroyo V. Hepatorenal syndrome. J Am Soc Nephrol 1999;10:1833-1839.
7. Gentilini P, Laffi G, Villa GL, Romanelli RG, Blendis LM. Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? J Hepatol 1999;31:1088-1097.
8. Jalan R, Forrest EH, Redhead DN, Dillon JF, Hayes PC. Reduction in renal blood flow following acute increases in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut 1997;40:664-670.
9. Lang F, Tschernko E, Schulze E, Ottl I, Ritter M, Volkl H, et al. Hepatorenal reflex regulating kidney function. HEPATOLOGY; 1991;14:590-594.
10. DiBona GF. Reflex regulation of renal sympathetic nerve activity in cirrhosis. In: Häussinger D, Jungermann K, eds. Liver and Nervous System. Falk Symposium 103. London: Kluwer Academic Publishers, 1998:315-319.
11. Ming Z, Smyth DD, Lautt WW. Decreases in hepatic portal flow trigger a hepatorenal reflex to inhibit renal sodium and water excretion in rats: role of adenosine. HEPATOLOGY; 2002;35:167-175.
12. Ming Z, Smyth DD, Lautt WW. Intrahepatic adenosine triggers a hepatorenal reflex to tegulate renal sodium and water excretion. Auton Neurosci 2001;93:1-7.
13. Ming Z, Fan YJ, Yang X, Lautt WW. Blockade of intrahepatic adenosine receptors improves urine excretion in cirrhotic rats induced by thioacetamide. J Hepatol 2005;42:680-686.
14. Koyoma S, Kanai K, Aibiki M, Fujita T. Reflex increase in renal nerve activity during acutely altered portal venous pressure. J Auton Nerv Syst 1988;23:55-62.
15. Thames MC, Kinugawa T, Dibner-Dunlap ME. Reflex sympathoexcitation by cardiac sympathetic afferents during myocardial ischemia: role of adenosine. Circulation 1993;87:1698-1704.
16. Vandier C, Conway AF, Landauer RC, Kumar P. Presynaptic action of adenosine on a 4-aminopyridine-sensitive current in the rat carotid body. J Physiol 1999;515:419-429.
17. Palmer TM, Jacobson KA, Stiles GL. Immunological identification of A2 adenosine receptors by two antipeptide antibody preparations. Molec Pharmacol 1992;42:391-397.
18. Dixon AK, Gubitz AK, Sirinathsinghji DJ, Richardson PJ, Freeman TC. Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 1996;118:1461-1468.
19. 2+ dependence of the response of three adenosine type receptors in rat hepatocytes. Eur J Pharmacol 1997;340:243-247.
20. 2 receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers. HEPATOLOGY 2000;32:297-302.
21. 2+ and cAMP. Eur J Pharmacol 2002;437:105-111.
22. Lautt WW. The 1995 Ciba-Geigy Award Lecture. Intrinsic regulation of hepatic blood flow. Can J Physiol Pharmacol 1996;74:223-233.
23. O'Grady JG. Acute liver failure. Postgrad Med J 2005;81:148-154.
24. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. HEPATOLOGY 2000;32:734-739.
25. O'Beirne JP, Chouhan M, Hughes RD. The role of infection and inflammation in the pathogenesis of hepatic encephalopathy and cerebral edema in acute liver failure. Nat Clin Pract Gastroenterol Hepatol 2006;3:118-119.
26. Javle P, Yates J, Kynaston HG, Parsons KF, Jenkins SA. Hepatosplanchnic haemodynamics and renal blood flow and function in rats with liver failure. Gur 1998;43:272-279.
27. Sherlock S. Vasodilatation associated with hepatocellular disease: relation to functional organ failure. Gut 1990;31:365-367.
28. Hunter A, Holscher MA, Neal RA. Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system. J Pharmacol Exp Ther 1977;200:439-448.
29. Porter WR, Neal RA. Metabolism of thioacetamide and thioacetamide S-oxide by rat liver microsomes. Drug Metab Dispos 1978;6:379-388.
30. Chilakapati J, Shankar K, Korrapati MC, Hill RA, Mehendale HM. Saturation toxicokinetics of thioacetamide: role in initiation of liver injury. Drug Metab Dispos 2005;33:1877-1885.
31. Caballero ME, Berlanga J, Ramirez D, Lopez-Saura P, Gozalez R, Floyd DN, et al. Epidermal growth factor reduces multiorgan failure induced by thioacetamide. Gut 2001;48:34-40.
32. Waters NJ, Waterfield CJ, Farrant RD, Holmes E, Nicholson JK. Metabonomic deconvolution of embedded toxicity: application to thioacetamide hepato- and nephrotoxicity. Chem Res Toxicol 2005;18:639-654.
33. Anand R, Harry D, Holt S, Milner P, Dashwood M, Goodier D, et al. Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure. Gut 2002;50:111-117.
34. Bontemps F, Vincent MF, Van-den-Berghe G. Mechanisms of elevation of adenosine levels in anoxic hepatocytes. Biochem J 1993;290:671-677.
35. Lloyd HE, Schrader J. The importance of the transmethylation pathway for adenosine metabolism in the heart. In: Gerlach E, Becker BF, eds. Topics and Perspectives in Adenosine Research. Berlin: Springer-Verlag, 1987:199-207.
36. Lautt WW, Legare DJ. The use of 8-phenyltheophylline as a competitive antagonist of adenosine and an inhibitor of the intrinsic regulatory mechanism of the hepatic artery. Can J Physiol Pharmacol 1985;63:717-722.
37. Richter S, Vollmar B, Mucke I, Post S, Menger MD. Hepatic arterioloportal venular shunting guarantees maintenance of nutritional microvascular supply in hepatic arterial buffer response of rat livers. J Physiol 2001;531:193-201.
38. Niijima A. An electrophysiological study on hepatovisceral reflex: the role played by vagal hepatic afferents from chemosensors in the hepatoportal tegion. In: Haussinger D, Jungermann K, eds. Liver and Nervous System. London: Kluwer Academic Publishers, 1998:159-172.
39. DiBona GF: Reflex regulation of renal sympathetic nerve activity in cirrhosis. In: Häussinger D, Jungermann K, eds. Liver and Nervous System. Falk Symposium 103. London: Kluwer Academic Publishers, 1998:315-319.
40. 1 adenosine receptor antagonist. Br J Pharmacol 1993;109:271-277.
41. Kost CK Jr, Herzer WA, Rominski BR, Mi Z, Jackson EK. Diuretic response to adenosine A(1) teceptor blockade in normotensive and spontaneously hypertensive rats: role of pertussis toxin-sensitive G-proteins. J Pharmacol Exp Ther 2000;292:752-760.
42. Hansen PB, Hashimoto S, Oppermann M, Huang Y, Briggs JP, Schnermann J. Vasoconstrictor and vasodilator effects of adenosine in the mouse kidney due to preferential activation of A1 or A2 adenosine receptors. J Pharmacol Exp Ther 2005;315:1150-1157.
43. Morita H, Matsuda T, Tanaka K, Hosomi H. Role of hepatic receptors in controlling body fluid homeostasis. Jpn J Physiol 1995;45:355-368.
44. Hosomi H, Morita H. Hepatorenal and hepatointestinal reflexes in sodium homeostasis. News Physiol Sci 1996;11:103-107.